Calithera Biosciences (CALA) Commences Underwritten Public Offering of Common

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/18/2026

1. VRNS
2. CRWV
3. JBHT
4. TSLA
5. GPRK
6. SCHW
7. TRV
8. TFC
9. TECHM:IN
10. NVDA

Go back to Calithera Biosciences (CALA) Commences Underwritten Public Offering of Common

Calithera Biosciences, Inc. Announces Commencement of Underwritten Public Offering of Common Stock

April 15, 2020 4:01 PM EDT

SOUTH SAN FRANCISCO, Calif., April 15, 2020 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical stage biotechnology company focused on discovering and developing novel small molecule drugs for the treatment of cancer and other life-threatening diseases, today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. All of the shares of common stock are being offered by Calithera.... More